Why the study?
Does adjuvant left-sided breast cancer radiotherapy increase serum hscTnT levels and associate with cardiac radiation doses in chemotherapy-naive breast cancer patients?
Does adjuvant left-sided breast cancer radiotherapy increase serum hscTnT levels and associate with cardiac radiation doses in chemotherapy-naive breast cancer patients?
Adjuvant radiotherapy for left-sided breast cancer induces acute subclinical myocardial damage, indicated by elevated hscTnT, which correlates with higher cardiac radiation doses.
No takes yet. Share an insight, caveat, or question.
May signal dose-related subclinical injury during left breast radiotherapy; leaves open whether troponin monitoring alters outcomes.
Skyttä et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: